Cargando…

Systematic Review of Pharmacogenetic Warfarin Dosing

Detalles Bibliográficos
Autores principales:	van Schie, Rianne M. F., Jorgensen, Andrea L., de Boer, Anthonius, Maitland-van der Zee, Anke-Hilse
Formato:	Texto
Lenguaje:	English
Publicado:	Springer-Verlag 2009
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2762507/ https://www.ncbi.nlm.nih.gov/pubmed/19693633 http://dx.doi.org/10.1007/s11606-009-1083-9

Ejemplares similares

Pharmacogenetics and pharmacogenomics: practical applications in routine medical practice
por: Maitland-van der Zee, Anke-Hilse, et al.
Publicado: (2010)

From evidence based medicine to mechanism based medicine. Reviewing the role of pharmacogenetics
por: Wilffert, Bob, et al.
Publicado: (2010)

Cost Effectiveness of New Oral Anticoagulants for Stroke Prevention in Patients with Atrial Fibrillation in Two Different European Healthcare Settings
por: Verhoef, Talitha I., et al.
Publicado: (2014)

Genetic Testing Before Anticoagulation? A Systematic Review of Pharmacogenetic Dosing of Warfarin
por: Kangelaris, Kirsten Neudoerffer, et al.
Publicado: (2009)

Pharmacogenomic insights into treatment and management of statin-induced myopathy
por: Peters, Bas JM, et al.
Publicado: (2009)

Risk of major bleeding among users of direct oral anticoagulants combined with interacting drugs: A population‐based nested case–control study
por: Zhang, Yumao, et al.
Publicado: (2020)

Efficacy and Safety Assessment of the Addition of Bevacizumab to Adjuvant Therapy Agents in Cancer Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Ahmadizar, Fariba, et al.
Publicado: (2015)

Correction: Efficacy and Safety Assessment of the Addition of Bevacizumab to Adjuvant Therapy Agents in Cancer Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Ahmadizar, Fariba, et al.
Publicado: (2015)

Warfarin dosing algorithms: A systematic review
por: Asiimwe, Innocent G., et al.
Publicado: (2020)

Comparison of Nine Statistical Model Based Warfarin Pharmacogenetic Dosing Algorithms Using the Racially Diverse International Warfarin Pharmacogenetic Consortium Cohort Database
por: Liu, Rong, et al.
Publicado: (2015)

Pharmacogenetics of warfarin in a paediatric population: Time in therapeutic range, initial and stable dosing, and adverse effects
por: Hawcutt, Daniel B, et al.
Publicado: (2014)

Warfarin-related nephropathy: possible role for the warfarin pharmacogenetic profile
por: Di Maso, Vittorio, et al.
Publicado: (2014)

Creating and validating a warfarin pharmacogenetic dosing algorithm for Colombian patients
por: Galvez, Jubby Marcela, et al.
Publicado: (2018)

Warfarin Anticoagulant Therapy: A Southern Italy Pharmacogenetics-Based Dosing Model
por: Mazzaccara, Cristina, et al.
Publicado: (2013)

Establishment of a Han Chinese-specific pharmacogenetic-guided warfarin dosing algorithm
por: Pei, Lin, et al.
Publicado: (2018)

Pharmacogenetics: The future medicine
por: Saini, Rajiv, et al.
Publicado: (2010)

Warfarin dose prediction in children using pharmacometric bridging—comparison with published pharmacogenetic dosing algorithms
por: Hamberg, Anna-Karin, et al.
Publicado: (2013)

Warfarin Pharmacogenetics: Challenges and Opportunities for Clinical Translation
por: Limdi, Nita A.
Publicado: (2012)

Change in prescription pattern as a potential marker for adverse drug reactions of angiotensin converting enzyme inhibitors
por: Mahmoudpour, Seyed Hamidreza, et al.
Publicado: (2015)

A Pharmacogenetics-Based Warfarin Maintenance Dosing Algorithm from Northern Chinese Patients
por: Chen, Jinxing, et al.
Publicado: (2014)

A Novel Admixture-Based Pharmacogenetic Approach to Refine Warfarin Dosing in Caribbean Hispanics
por: Duconge, Jorge, et al.
Publicado: (2016)

Pharmacogenetic-Guided Algorithm to Improve Daily Dose of Warfarin in Elder Han-Chinese Population
por: Ren, Yirong, et al.
Publicado: (2020)

Machine Learning Algorithm for Predicting Warfarin Dose in Caribbean Hispanics Using Pharmacogenetic Data
por: Roche-Lima, Abiel, et al.
Publicado: (2020)

A Randomized Trial of Pharmacogenetic Warfarin Dosing in Naïve Patients with Non-Valvular Atrial Fibrillation
por: Pengo, Vittorio, et al.
Publicado: (2015)

Erratum to: Warfarin dose prediction in children using pharmacometric bridging – comparison with published pharmacogenetic dosing algorithms
por: Hamberg, Anna-Karin, et al.
Publicado: (2013)

Genetic Variations and Cisplatin Nephrotoxicity: A Systematic Review
por: Zazuli, Zulfan, et al.
Publicado: (2018)

Warfarin pharmacogenetics: How close are we to clinical practice?
por: Gaikwad, Tejasvita, et al.
Publicado: (2013)

Warfarin Dosage Response Related Pharmacogenetics in Chinese Population
por: Li, Siyue, et al.
Publicado: (2015)

Pharmacogenetics-Based versus Conventional Dosing of Warfarin: A Meta-Analysis of Randomized Controlled Trials
por: Shi, Changcheng, et al.
Publicado: (2015)

Is the use of warfarin becoming obsolete?
por: Haykal, Tarek, et al.
Publicado: (2021)

The effect of the VKORC1 promoter variant on warfarin responsiveness in the Saudi WArfarin Pharmacogenetic (SWAP) cohort
por: Al Ammari, Maha, et al.
Publicado: (2020)

IL1RL1 gene variations are associated with asthma exacerbations in children and adolescents using inhaled corticosteroids
por: Dijk, F. Nicole, et al.
Publicado: (2019)

Warfarin-quetiapine interaction causing hemorrhage
por: Bavle, Amar D., et al.
Publicado: (2016)

Warfarin overdose with a side of munchausen
por: Mohammed, Denelle
Publicado: (2019)

Successful Treatment of Livedoid Vasculitis with Primary Antiphospholipid Syndrome by Using Aspirin and Low Dose Warfarin Combination Therapy
por: So, Byoung Joon, et al.
Publicado: (2015)

Response to “Letter to the Editor: Coronavirus disease 2019 (COVID-19) markedly increased mortality in patients with hip fracture: A systematic review and meta-analysis”
por: Lim, Michael Anthonius, et al.
Publicado: (2021)

Profiling of warfarin pharmacokinetics‐associated genetic variants: Black Africans portray unique genetic markers important for an African specific warfarin pharmacogenetics‐dosing algorithm
por: Ndadza, Arinao, et al.
Publicado: (2021)

Beyond warfarin: The advent of new oral anticoagulants
por: Malhotra, Konark, et al.
Publicado: (2016)

Beware of upper airway obstruction in warfarinized patients
por: Magos, Tiarnan, et al.
Publicado: (2018)

Comparison of Myelotoxicity and Nephrotoxicity Between Daily Low-Dose Cisplatin With Concurrent Radiation and Cyclic High-Dose Cisplatin in Non-Small Cell Lung Cancer Patients
por: Zazuli, Zulfan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_40r1tfjohvjp49an0hgcdrhuob